DOV
65
-4
LRCX
37
-9
T
48
3
NOC
41
9
UPS
48
2
GM
74
5
MCO
71
-7
RCL
83
-2
USB
50
-3
APH
65
-3
OMC
50
-16
JNPR
50
-6
XEL
67
2
CCI
30
-11
A
37
-2
RL
69
-4
AIV
64
4
SJM
9
-5
DTE
43
5
PVH
60
-4
DOV
65
-4
LRCX
37
-9
T
48
3
NOC
41
9
UPS
48
2
GM
74
5
MCO
71
-7
RCL
83
-2
USB
50
-3
APH
65
-3
OMC
50
-16
JNPR
50
-6
XEL
67
2
CCI
30
-11
A
37
-2
RL
69
-4
AIV
64
4
SJM
9
-5
DTE
43
5
PVH
60
-4
Financhill
Back

Transcat Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
40

TRNS
Transcat

Last Price:
103.40
Seasonality Move:
5.47%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
40
Transcat (TRNS) is a Sell

Is Transcat a Buy, Sell or Hold?

  • The current Transcat [TRNS] share price is $103.42. The Score for TRNS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • TRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRNS Stock Price Chart

What is Transcat's stock price today?

  • The Transcat share price today is $103.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRNS is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

TRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.91 Sell
Relative Strength Index (14 RSI): 38.56 Sell
Chaikin Money Flow: -76760 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.19 - 125.65) Sell
Bollinger Bands (100): (110.81 - 131.15) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

TRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.36 Sell
20-day SMA: 109.67 Sell
50-day SMA: 118.03 Sell
200-day SMA: 117.66 Sell
8-day EMA: 106.4 Sell
20-day EMA: 109.48 Sell
50-day EMA: 115.17 Sell
200-day EMA: 115.35 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Transcat Earnings Growth & TRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.09 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Transcat Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):